By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aradigm Corporation 

3929 Point Eden Way

Hayward  California  94545  U.S.A.
Phone: 510-265-9000 Fax: 510-265-0277




Novo Nordisk A/S  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

GlaxoSmithKline  Agreement to develop AERx technology for the delivery of morphine and fentanyl for pain management.

University Of Torino  Aradigm has additional undisclosed partnerships with both platforms looking at developmental and marketed products.

GlaxoSmithKline (North Carolina) 

Company News
Aradigm (ARDM) Announces First Quarter 2017 Financial Results 5/15/2017 7:19:32 AM
Aradigm (ARDM) Announces Fourth Quarter 2016 And Full Year Financial Results 3/28/2017 7:40:00 AM
Bay Area's Aradigm (ARDM) Stock Plunges After Posting Mixed-Data of Two Phase III Antibiotic Studies 12/1/2016 6:57:44 AM
Aradigm Corporation (ARDM) Announces Third Quarter 2016 Financial Results 11/9/2016 12:44:36 PM
Multi-million Dollar DTRA Funding For Biodefense Research With Aradigm Corporation (ARDM)'s Inhaled Ciprofloxacin 10/18/2016 1:56:44 PM
Compugen Ltd. (CGEN) To Present At The Annual Meeting Of The Society For Immunotherapy Of Cancer Next Month 10/7/2016 8:56:33 AM
Aradigm Corporation (ARDM) Announces Last Patient Dosing Visit In ORBIT-3 And ORBIT-4 Phase 3 Studies Of Pulmaquin In Non-Cystic Fibrosis Bronchiectasis Patients 9/22/2016 11:18:48 AM
Aradigm Corporation (ARDM) To Host Analyst Meeting And Webcast On September 26 In New York City 9/21/2016 11:02:26 AM
Aradigm Corporation (ARDM) To Present At The Ladenburg Thalmann 2016 Healthcare Conference On September 27 9/20/2016 11:40:14 AM
Aradigm Corporation (ARDM) Release: Two Presentations On Aradigm’s Inhaled Liposomal Ciprofloxacin Programs At The American Thoracic Society 2016 International Conference 5/11/2016 11:05:12 AM